Experts debate MMR/p53 testing, liquid biopsy, and immunotherapy sequencing in endometrial cancer, refining prognosis and relapse treatment.

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

At least eight babies have been born to patients who underwent the procedure. This week I want to tell you about an ...

GSK announced today that Quebec has become the first Canadian province to publicly reimburse Jemperli (dostarlimab for ...

Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

The market opportunities in the Global Uterine Cancer Therapeutics & Diagnostics Market include the increased demand for ...

While there's no specific screening test for endometrial cancer, awareness and genetic profiles of the tumors are saving ...

Uterine fibroids are a common benign gynecological condition affecting many women of reproductive age. However, not all cases ...

Mumbai: Unlike many senior citizens, Thane-based grandmother Saroj Dhonde never took medicines for chronic conditions like ...

Robert J. DeBernardo, MD, discusses how understanding and treatment of endometrial cancer have evolved dramatically, allowing for more personalized care that directly benefits patients. Instead of a ...

Dana M. Chase, MD, describes how, over the past several decades, treatment for endometrial cancer has advanced significantly, shifting from open surgeries with extensive recovery to minimally invasive ...